William Blair Starts Korro Bio Inc. (KRRO) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Korro Bio Inc. (KRRO) PT Lowered to $95 at RBC Capital
August 14, 2024 6:26 AM EDTRBC Capital analyst Luca Issi lowered the price target on Korro Bio Inc. (NASDAQ: KRRO) to $95.00 (from $105.00) while maintaining a Outperform rating.
The analyst comments "Story is on track, with lead candidate for A1AT poised to enter the clinic soon... More



